A clinical trial record update dated October 2, 2026 lists the study "An Investigational Study of Hydrocortisone" as completed. The trial, registered under identifier NCT01960530, was conducted as a Phase 1 study. According to the record, the current status is COMPLETED. No additional details such as results, enrollment figures, or efficacy outcomes were included in this update. The record does not specify whether results have been posted separately on the registry. This update pertains to hydrocortisone, a compound related to corticotropin pathways, and corticotropin itself carries an approved regulatory status. No safety findings, adverse events, or comparative data are included in the available information. Readers should note that a "completed" status reflects only the conclusion of the trial's defined activities as recorded, not any specific conclusion about the study's findings. For further context on this compound, including its approved regulatory status and general background, readers can consult the compound overview.
Phase 1 Hydrocortisone Trial Linked to Corticotropin Marked Completed
See the full corticotropin overview
Source: https://clinicaltrials.gov/study/NCT01960530